JENNIFER PRESTON: Open Payments
NPI 1073542502 · WILMINGTON, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$827 in 38 payments from 13 companies in 2025. Trend: 2023 $695 · 2024 $877 · 2025 $827
Food & beverage: $827
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 20 | $397 |
| Boston Scientific Corporation | 1 | $121 |
| Janssen Biotech, Inc. | 5 | $89 |
| Aimmune Therapeutics, Inc. | 2 | $38 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $35 |
| Ipsen Biopharmaceuticals, Inc | 1 | $22 |
| Intercept Pharmaceuticals, Inc. | 1 | $22 |
| Madrigal Pharmaceuticals | 1 | $19 |
| Ardelyx, Inc. | 1 | $18 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $18 |
Products named: MAVYRET, Axonics, RINVOQ, TREMFYA, SKYRIZI, LINZESS, CREON, ENTYVIO.
Industry payments across NC — which companies pay providers there.
